{
  "paper_metadata": {
    "pmid": null,
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on KCNH2 variants, including penetrance data and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1682A>G",
      "protein_notation": "p.Ala561Val",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "not specified",
        "phenotype": "Long QT syndrome type 2"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 25,
          "age_at_onset": 20,
          "age_at_diagnosis": 22,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "experienced syncope and palpitations",
          "evidence_sentence": "Case 1 presented with syncope at age 20."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with LQT2 after family screening",
          "evidence_sentence": "Case 2 was diagnosed with LQT2 at age 29."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 15,
          "age_at_onset": 14,
          "age_at_diagnosis": 15,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms but carries the variant",
          "evidence_sentence": "Case 3 is a carrier but remains asymptomatic."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": 35,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "diagnosed with LQT2 but no symptoms",
          "evidence_sentence": "Case 4 was diagnosed at age 35 but has not experienced symptoms."
        }
      ],
      "functional_data": {
        "summary": "The A561V variant showed impaired trafficking and function in vitro.",
        "assays": [
          "Western blot",
          "Patch-clamp technique"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not reported in gnomAD.",
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The L539fs/47 variant was mentioned but not included as it does not belong to KCNH2.",
      "key_quotes": [
        "ALLN can restore HERG-A561V mutant protein trafficking process.",
        "The molecular chaperone CNX/CRT may affect the normal transport of mutant proteins."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}